News related to Proquin XR (Ciprofloxacin) and/or conditions it is approved for
Aradigm Presents Phase 2 Data On Inhaled Liposomal Ciprofloxacin In Cystic Fibrosis At The North American Cystic Fibrosis Conference
Source: Cystic Fibrosis News From Medical News Today [2008.10.26]
Aradigm Corporation (OTCBB: ARDM) it is presenting data from its Phase 2 study of inhaled liposomal ciprofloxacin (ARD-3100) in cystic fibrosis (CF) patients at the 22nd Annual North American Cystic Fibrosis (NACF) conference in Orlando, Florida. Completed in June 2008, the study was an open-label, two week efficacy and safety trial of once daily inhaled liposomal ciprofloxacin in 22 CF patients conducted at leading CF centers in Australia and New Zealand.
ciprofloxacin/dexamethasone-otic suspension, Ciprodex
Source: MedicineNet Ear Tubes Specialty [2005.03.02]
Title: ciprofloxacin/dexamethasone-otic suspension, Ciprodex
Category: Medications
Created: 3/2/2005
Last Editorial Review: 3/2/2005
|
